Dr Gosia Trynka, Group Leader at the Wellcome Sanger Institute, has been awarded the 2020 Leena Peltonen prize by the European Society for Human Genetics (ESHG). This prize is given every two years to an outstanding young researcher in the field of human genetics.
Sanger researcher wins prize from European Society for Human Genetics
The prize honours the memory of Dr Leena Peltonen, a world-renowned human geneticist from Finland. Head of Human Genetics at the Sanger Institute when she died in 2010, Dr Peltonen was a visionary geneticist, champion of population genetics and public health, who contributed greatly to the identification of disease genes for human diseases.
Dr Trynka gave the award lecture during the Opening Ceremony for the European Society of Human Genetics annual meeting on 6th June, held online this year. She has been leading the Immune Genomics Group at the Sanger Institute since 2014. This year she also took on an additional responsibility as the Experimental Science Director at Open Targets, a public/private partnership that uses genomics data to improve drug target identification and prioritisation.
Her group at the Sanger Institute combines immunology and genomic assays with statistical approaches to study how human genetic variation impacts the immune system and predisposes to the development of autoimmune diseases.
The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.